Company registration number 14037443 (England and Wales)
OCCAM'S REMEDY APR LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
PAGES FOR FILING WITH REGISTRAR
OCCAM'S REMEDY APR LIMITED
CONTENTS
Page
Directors' report
1
Balance sheet
2
Notes to the financial statements
3
OCCAM'S REMEDY APR LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 30 APRIL 2025
- 1 -

The directors present their annual report and financial statements for the year ended 30 April 2025.

Principal activities

The principal activity of the company continued to be that insurance and pension funding activities

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

G Draper
M G Fordham
(Appointed 10 December 2024)
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
G Draper
Director
15 April 2025
OCCAM'S REMEDY APR LIMITED
BALANCE SHEET
AS AT 30 APRIL 2025
30 April 2025
- 2 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
2,000
2,000
Net current assets
2,000
2,000
Capital and reserves
Called up share capital
2,000
2,000

For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 15 April 2025 and are signed on its behalf by:
G Draper
Director
Company registration number 14037443 (England and Wales)
OCCAM'S REMEDY APR LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
- 3 -
1
Accounting policies
Company information

Occam's Remedy APR Limited is a private company limited by shares incorporated in England and Wales. The registered office is Branksome, Deepdene Park Road, Dorking, Surrey, RH5 4AL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
-
0
-
0
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
2,000
2,000
2025-04-302024-05-01falsefalsefalse15 April 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityG DraperM G Fordham140374432024-05-012025-04-3014037443core:PriorPeriodIncreaseDecrease2024-05-012025-04-3014037443bus:Director12024-05-012025-04-3014037443bus:Director22024-05-012025-04-30140374432025-04-30140374432024-04-3014037443core:ShareCapital2025-04-3014037443core:ShareCapital2024-04-30140374432023-05-012024-04-3014037443core:WithinOneYear2025-04-3014037443core:WithinOneYear2024-04-3014037443bus:PrivateLimitedCompanyLtd2024-05-012025-04-3014037443bus:SmallCompaniesRegimeForAccounts2024-05-012025-04-3014037443bus:FRS1022024-05-012025-04-3014037443bus:AuditExemptWithAccountantsReport2024-05-012025-04-3014037443bus:FullAccounts2024-05-012025-04-30xbrli:purexbrli:sharesiso4217:GBP